Shanghai Raas Blood Products Coltdor Shanghai Raas For Shortstock Symbol002252Being Set Up Bytheunited States Rareantibody Antigen Supply Inc And Theshanghai Blood Products Blood Transfusion Equipment Companyin October1988Was Thefirst Largesino Foreign Joint Venturein Production Ofblood Products In March2007Shanghai Raas Was Trasferred To Limited Company As A Wholeand Its Registed Capital Was12 000Yuan And Kerui Tiancheng Klc Holdings Ltd And Raas China Ltd Both Invested 50Of It In Order To Improvethelevel Of Medical Careand Health Carein China And Other Developing Countriesshanghai Raas Research I Oeinvent And Develop New Products For Thetreatment Of Blood Diseasestomeet Thedemand Of Themarket For High Quality Blood Products Sinceit Was Founded 28 Years Agoraas Has Been Adhering To Thequality Policy Of Safehigh Qualityhigh Efficiency Aeand It Has Created 11Products Covering Threecategories Of Blood Productshuman Blood Proteinshuman Immunoglobulin And Blood Coagulation Factor Shanghai Raas Will Actively Integrateglobal Resources By Layouting Innovation Chains Around Theblood Products Industry And Buildingthreeinnovation Fulcrums Among National Think Tank Industrial Research Instituteand International Laboratory To Form Theinnovation Ecosystem In Blood Products Industry By Taking Internal Growth As Theroot And Taking Epitaxialm & A As Thecrossraas Will Making Every Effort To Bethenational Aircraft Carrier Enterpriseof Theworld S Blood Products Industry
